Overview
Cinta Lleixa practices in Madrid, Spain. Lleixa is rated as an Advanced expert by MediFind in the treatment of Chronic Polyradiculoneuritis. Their top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Demyelinizing Neuropathy with IgM Monoclonal, Guillain-Barre Syndrome, and Delta-Sarcoglycanopathy.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Chronic Polyradiculoneuritis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Inflammatory Demyelinating Polyneuropathy
- Advanced
- Chronic Demyelinizing Neuropathy with IgM Monoclonal
- Chronic Polyradiculoneuritis
- Delta-SarcoglycanopathyLleixa isAdvanced. Learn about Delta-Sarcoglycanopathy.
- Guillain-Barre SyndromeLleixa isAdvanced. Learn about Guillain-Barre Syndrome.
- Experienced
- ADULT SyndromeLleixa isExperienced. Learn about ADULT Syndrome.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Brown SyndromeLleixa isExperienced. Learn about Brown Syndrome.
- CardiomyopathyLleixa isExperienced. Learn about Cardiomyopathy.
- DermatomyositisLleixa isExperienced. Learn about Dermatomyositis.
- Limb-Girdle Muscular DystrophyLleixa isExperienced. Learn about Limb-Girdle Muscular Dystrophy.